CC BY-NC-ND 4.0 · J Lab Physicians 2020; 12(03): 212-218
DOI: 10.1055/s-0040-1721159
Review Article

Effectiveness of Sample Pooling Strategies for SARS-CoV-2 Mass Screening by RT-PCR: A Scoping Review

Sangeeta Deka
1   Department of Microbiology, All India Institute of Medical Sciences, Rishikesh, Virbhadra Road, Rishikesh, Uttarakhand, India
,
Deepjyoti Kalita
1   Department of Microbiology, All India Institute of Medical Sciences, Rishikesh, Virbhadra Road, Rishikesh, Uttarakhand, India
› Author Affiliations
Funding None.

Abstract

The ongoing COVID-19 pandemic has hugely impacted the economy of many countries, and there is an acute shortage of diagnostic resources. With the exponential increase in the number of cases and necessity to screen large number of people, there is a steep increase in the demand for diagnostic kits. Pooled-sample testing is a promising strategy to screen a large population rapidly with limited resources. The aim of this work was to compile a cohesive literature review of the effectiveness and accuracy of pooled-sample testing in the detection of SARS-CoV-2 and critically analyze its limitations. Medline, Google Scholar, Embase, and preprint servers (e.g., bioRxiv) were searched for literature on pooled testing for diagnosis of COVID-19, and out of initial 60 articles/reports, nine original articles were retained. Optimal pool size (number of samples in a pool) seemed to be dependent on factors like prevalence or rate of positivity in community. In low-prevalence localities pool size of around 30 seemed to be effective as observed by some authors. All the researchers had found significant reduction in number of tests (depending on pool size, stages, and pooling design), leading to conservation of resources. Pooling can be done with extracted RNA eluate or directly with patient’s sample before extraction. This leads to further reduction in consumables, time and manpower. Risk of false negativity in samples with high-threshold cycle (i.e., low-viral load) value was a concern. Some researchers suggest adding few additional cycles to lower the chances of missing positive cases with low-Ct value. Lower limit of detection (LoD) of RT-PCR kits, that is, sensitivity of kits was another factor to consider. Thus, in a country like India, given the economic benefit and scarcity of resources, pooling strategy can be very effective, especially in low-prevalence areas and in low-risk contacts.



Publication History

Article published online:
23 November 2020

© 2020. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5 (04) 536-544
  • 2 WHO. Coronavirus disease (COVID-19) Pandemic. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed July 31, 2020
  • 3 WHO. WHO timeline - COVID-19. Available at: https://www.who.int/news-room/detail/27-04-2020-who-timeline—covid-1. Accessed July 31, 2020
  • 4 Indian Council of Medica Research. SARS-CoV-2 (COVID-19) testing status. Available at: http://www.icmr.gov.in. Accessed June 21, 2020
  • 5 Bar-On YM, Flamholz A, Phillips R, Milo R. SARS-CoV-2 (COVID-19) by the numbers. eLife 2020; (e-pub ahead of print) DOI: 10.7554/eLife.57309.
  • 6 Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill 2020; 25 (04) 2000058
  • 7 Van TT, Miller J, Warshauer DM. et al. Pooling nasopharyngeal/throat swab specimens to increase testing capacity for influenza viruses by PCR. J Clin Microbiol 2012; 50 (03) 891-896
  • 8 Theagarajan LN. Group testing for COVID-19: how to stop worrying and test more. 2020; Available at: https://arxiv.org/abs/2004.06306v2. Accessed July 31, 2020
  • 9 Yelin I, Aharony N, Tamar ES. et al. Evaluation of COVID-19 RT-qPCR test in multi-sample pools. Clin Infect Dis 2020; (e-pub ahead of print) DOI: 10.1093/cid/ciaa531.
  • 10 Lohse S, Pfuhl T, Berkó-Göttel B. et al. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. Lancet Infect Dis 2020; (e-pub ahead of print) DOI: 10.1016/S1473-3099(20)30362-5.
  • 11 Deckert A, Kyei NNA. Pooled-sample analysis strategies for COVID-19 mass testing: a simulation study. Available at: https://www.who.int/bulletin/online_first/20-257188.pdf. Accessed June 1, 2020
  • 12 Abdalhamid B, Bilder CR, McCutchen EL, Hinrichs SH, Koepsell SA, Iwen PC. Assessment of specimen pooling to conserve SARS CoV-2 testing resources. Am J Clin Pathol 2020; 153 (06) 715-718
  • 13 Hogan CA, Sahoo MK, Pinsky BA. Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2. JAMA 2020; 323 (19) 1967-1969
  • 14 Gupta E, Padhi A, Khodare A, et. al. Pooled RNA sample reverse transcriptase real time PCR assay for SARS CoV -2 infection: a reliable, faster and economical method. Available at: https://www.medrxiv.org/content/10.1101/2020.04.25.20079095v1. Accessed July 31, 2020
  • 15 Eberhardt JN, Breuckmann NP, Eberhardt CS. Multi-stage group testing improves efficiency of large-scale COVID-19 screening. J Clin Virol 2020; (e-pub ahead of print) DOI: 10.1016/j.jcv.2020.104382.
  • 16 Shani-Narkiss H, Gilday OD, Yayon N, Landau ID. Efficient and practical sample pooling for high-throughput PCR diagnosis of COVID-19. Available at: https://www.medrxiv.org/content/10.1101/2020.04.06.20052159v2. Accessed July 31, 2020
  • 17 Sinnott-Armstrong N, Klein DL, Hickey B. Evaluation of group testing for SARS-CoV-2 RNA. 2020;1–11. Available at: https://www.medrxiv.org/content/10.1101/2020.03.27.20043968v1. Accessed July 31, 2020
  • 18 Hanel R, Thurner S. Boosting test-efficiency by pooled testing strategies for SARS-CoV-2. Available at: http://arxiv.org/abs/2003.09944. Accessed on June 1, 2020
  • 19 Nguyen NT, Aprahamian H, Bish EK, Bish DR. A methodology for deriving the sensitivity of pooled testing, based on viral load progression and pooling dilution. J Transl Med 2019; 17 (01) 252
  • 20 Gollier C, Gossner O. Group testing against Covid-19. Available at: https://hal.archives-ouvertes.fr/hal-02550740. Accessed July 31, 2020
  • 21 Taufer M. Rapid, large-scale, and effective detection of COVID-19 via non-adaptive testing. Available at: https://www.biorxiv.org/content/10.1101/2020.04.06.028431v1. Accessed on June 1, 2020
  • 22 Szapudi I. Efficient sample pooling strategies for COVID-19 data gathering. Available at: http://medrxiv.org/content/early/2020/04/07/2020.04.05.20054445. Accessed on June 2,2020
  • 23 Zhu J, Rivera K, Baron D. Noisy pooled PCR for virus testing. Available at: http://medrxiv.org/content/early/2020/04/11/2020.04.06.20055384. Accessed June2, 2020
  • 24 Noriega R, Samore MH. Increasing testing throughput and case detection with a pooled-sample Bayesian approach in the context of COVID-19. Available at: https://www.biorxiv.org/content/10.1101/2020.04.03.024216v1. Accessed June 2, 2020